Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scinus Cell Expansion is a Netherlands-based biotechnology company that specializes in developing advanced bioprocessing technology for the cell therapy industry. The company's flagship product, the SCINUS Cell Expansion System, is a closed, automated, and scalable bioreactor designed specifically for the cost-effective cultivation of adherent cells, such as Mesenchymal Stem Cells (MSCs). By providing a controlled environment that mimics physiological conditions, Scinus enables researchers and clinicians to produce high-quality cell products at a lower cost compared to traditional plasticware. The technology aims to bridge the gap between laboratory-scale research and large-scale clinical production, facilitating the wider adoption of regenerative medicine. Their system is particularly noted for its ability to scale volume within a single bag, reducing the risk of contamination and labor intensity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scinus Cell Expansion Company.